#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Shyam Pattabiraman Email
Chief Financial Officer . Jubilant Therapeutics
Bedminster, NJ
Locations*****************@jubilanttx.com
Primary EmailHow to contact Shyam Pattabiraman
Join and see Shyam's contact info for free!Current Roles
Employees:
17Revenue:
$2.6MAbout
Jubilant Therapeutics is a patient-focused biopharmaceutical company advancing potent and selective small molecule modulators to address specific unmet medical needs in oncology and autoimmune diseases. The company’s leadership and scientific team are science-driven executives with global pharma background and experience in advancing innovative drug candidates into the clinic. Jubilant Therapeutics is headquartered in the U.S. with independent board and management, guided by globally renowned KOLs and SAB. Key Therapeutic Areas • Oncology • Auto-immune Disorders Portfolio • Novel PAD4 inhibitors targeting auto-immune disorders • Dual LSD1/HDAC6 inhibitors targeting cancer • Novel small molecule PD-L1 inhibitors • Novel brain penetrating PRMT5 inhibitors targeting cancerJubilant Therapeutics Address
1430 US Highway 206Bedminster, NJ